跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TEVA-NALOXONE NASAL SPRAY - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TEVA-NALOXONE NASAL SPRAY
Authorized
STANDARD
TEVA-NALOXONE NASAL SPRAY
teva canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
f81698494c4281e8
Company
teva canada limited
Type
Standard
Approval Details
Approval Id
f81698494c4281e8
Drug Approval Canada Name
TEVA-NALOXONE NASAL SPRAY
Product Name
TEVA-NALOXONE NASAL SPRAY
Status
Marketed
Status Date
2024-01-08
Original Market Date
2024-01-08
Din
02511568
Drug Class
Human
Dosage Form
Spray, Metered Dose
Route Of Administration
Nasal
Schedule
Ethical
Ahfs
28:10.00
Atc Original
V03AB15 NALOXONE
Atc Name
v 03 ab 15
Aig Number
0108981005
Company Name
teva canada limited
Company Address
30 Novopharm Court, Toronto, Ontario, Canada, M1B 2K9
Active Ingredients
NALOXONE HYDROCHLORIDE
4 MG / 0.1 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
f81698494c4281e8
Type
Standard
Back to Health Canada Approvals